Education
About Us
Working with TipRanks
Follow Us
Japan Tissue Engineering Co., Ltd. (JP:7774)
:7774
7774 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥430.00 - ¥811.00
Previous CloseN/A
Volume17.40K
Average Volume (3M)34.56K
Market Cap
¥18.56B
Enterprise Value¥14.73B
Total Cash (Recent Filing)¥4.07B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)―
Beta0.72
Next Earnings
Apr 24, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.77
Shares Outstanding40,610,200
10 Day Avg. Volume39,380
30 Day Avg. Volume34,563
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Japan Tissue Engineering Co., Ltd. News
PremiumCompany Announcements
Japan Tissue Engineering and Sysmex Enhance Regenerative Medicine
PremiumCompany Announcements
Japan Tissue Engineering Reports Q2 Financial Results
PremiumCompany Announcements
Japan Tissue Engineering Unveils Vitiligo Treatment ‘JACEMIN’
PremiumCompany Announcements
Japan Tissue Engineering Advances Burn Treatment
PremiumCompany Announcements
Japan Tissue Engineering Faces Q1 Earnings Decline---
7774 FAQ
What was Japan Tissue Engineering Co., Ltd.’s price range in the past 12 months?
Japan Tissue Engineering Co., Ltd. lowest stock price was ¥430.00 and its highest was ¥811.00 in the past 12 months.
What is Japan Tissue Engineering Co., Ltd.’s market cap?
Japan Tissue Engineering Co., Ltd.’s market cap is ¥18.56B.
When is Japan Tissue Engineering Co., Ltd.’s upcoming earnings report date?
Japan Tissue Engineering Co., Ltd.’s upcoming earnings report date is Apr 24, 2025 which is in 22 days.
How were Japan Tissue Engineering Co., Ltd.’s earnings last quarter?
Japan Tissue Engineering Co., Ltd. released its earnings results on Jan 31, 2025. The company reported -¥3.07 earnings per share for the quarter, missing the consensus estimate of N/A by -¥3.07.
Is Japan Tissue Engineering Co., Ltd. overvalued?
According to Wall Street analysts Japan Tissue Engineering Co., Ltd.’s price is currently Overvalued.
Does Japan Tissue Engineering Co., Ltd. pay dividends?
Japan Tissue Engineering Co., Ltd. does not currently pay dividends.
What is Japan Tissue Engineering Co., Ltd.’s EPS estimate?
Japan Tissue Engineering Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Japan Tissue Engineering Co., Ltd. have?
Japan Tissue Engineering Co., Ltd. has 40,610,200 shares outstanding.
What happened to Japan Tissue Engineering Co., Ltd.’s price movement after its last earnings report?
Japan Tissue Engineering Co., Ltd. reported an EPS of -¥3.07 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.806%.
Which hedge fund is a major shareholder of Japan Tissue Engineering Co., Ltd.?
Currently, no hedge funds are holding shares in JP:7774
---
Company Description
Japan Tissue Engineering Co., Ltd.
Japan Tissue Engineering Co., Ltd. engages in the regenerative medicine business in Japan. The company operates through Regenerative Medicine Product, Regenerative Medicine Outsourcing, and Research and Development Support segments. It offers autologous cultured epidermis, cartilage, corneal epithelium, and oral mucosal epithelium to medical institutions for the purpose of medical treatment. The company also provides tissue-engineered medical products. In addition, it researches and develops human 3-dimensional cultured tissue models for use in the development of cosmetics and drugs for external use, as well as in research that employs skin and cornea tissues. Further, the company offers regenerative medicine contract development and manufacturing services. The company was founded in 1999 and is headquartered in Gamagori, Japan. Japan Tissue Engineering Co., Ltd. is a subsidiary of Teijin Limited.
---
Technical Analysis
Otsuka Holdings Co
―
Peptidream
―
NanoCarrier Co., Ltd.
―
Healios KK
―
Takara Bio Inc.
―
---